Dear Neil,
I already published my thoughts about this order and the role of China as well as how can we use more telemedicine and digital health to fill the gap in Research Gate yesterday. [*see note below]
https://www.researchgate.net/publication/388753686_How_China_Benefits_fr...
But of course this will not be the solution which solves all the problems caused by President Trump and his team, as we still need people, material and medication for treatment.
Best
Anna
Anna E. Schmaus-Klughammer (LLB hons)
Vorstand / President
Former Member of the Scientific Staff - Hochschule Deggendorf
One World Medical Network e.V.
Ulrichsbergerstrasse 17
94469 Deggendorf
Germany
E-Mail schmaus@owmn.org
Phone 0171 4329606
Web www.owmn.org
One World Medical Network e.V.
Bank: Sparkasse Deggendorf, Germany
IBAN: DE43 7415 0000 0420 2385 52
BIC: BYLADEM1DEG4
HIFA profile: Anna E Schmaus-Klughammer is president of the association "One World Medical Network". The goal of the association is to improve medical care in LMICs (Low and Middle Income Countries).Our activities start from building primary and specialized health care facilities and continue to organize national cancer screening with connections to national and international expert doctors using telemedicine networks. Training of medical personnel is also an important part of the work of the association.
One World Medical Network e.V., Ulrichsbergerstrasse 17, Deggendorf in Germany.
info AT owmn.org www.owmn.org
[*Note from HIFA moderator (NPW): Thank you Anna. The abstract states: 'The dismantling of USAID creates a global development vacuum, benefiting China, which can expand its influence through the Belt and Road Initiative (BRI). While China focuses on infrastructure and financial aid, digital health and telemedicine offer an alternative, particularly in healthcare access, medical training, and public health monitoring. Klughammer’s cost-effective solutions, like Case.io and Telko.live, could help sustain healthcare services where USAID funding has been lost. However, funding constraints, regulatory barriers, and competition from China pose challenges. Success will depend on scalable deployment and strategic partnerships.']